Authors:
Sherer, Y
Levy, Y
Langevitz, P
Rauova, L
Fabrizzi, F
Shoenfeld, Y
Citation: Y. Sherer et al., Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases, PHARMACOL, 62(3), 2001, pp. 133-137
Authors:
Terryberry, JW
Shoenfeld, Y
Sherer, Y
Levy, Y
Fabrizzi, F
Ahmed, A
Peter, JB
Citation: Jw. Terryberry et al., Detection of antibodies to gangliosides and glycolipids in various intravenous immunoglobulin (IVIg) preparations, IMMUNOL INV, 29(3), 2000, pp. 337-347
Authors:
Levy, Y
Sherer, Y
Langevitz, P
Lorber, M
Rotman, P
Fabrizzi, F
Shoenfeld, Y
Citation: Y. Levy et al., Skin score decrease in systemic sclerosis patients treated with intravenous immunoglobulin - A preliminary report, CLIN RHEUMA, 19(3), 2000, pp. 207-211
Authors:
Sherer, Y
Langevitz, P
Levy, Y
Fabrizzi, F
Shoenfeld, Y
Citation: Y. Sherer et al., Treatment of chronic bilateral pleural effusions with intravenous immunoglobulin and cyclosporin, LUPUS, 8(4), 1999, pp. 324-327
Authors:
Sherer, Y
Levy, Y
Langevitz, P
Lorber, M
Fabrizzi, F
Shoenfeld, Y
Citation: Y. Sherer et al., Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin, CLIN RHEUMA, 18(2), 1999, pp. 170-173